Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media

Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed... Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media CHRISTOPHER C. YANG, HAODONG YANG, and LING JIANG, Drexel University Postmarketing drug safety surveillance is important because many potential adverse drug reactions cannot be identified in the premarketing review process. It is reported that about 5% of hospital admissions are attributed to adverse drug reactions and many deaths are eventually caused, which is a serious concern in public health. Currently, drug safety detection relies heavily on voluntarily reporting system, electronic health records, or relevant databases. There is often a time delay before the reports are filed and only a small portion of adverse drug reactions experienced by health consumers are reported. Given the popularity of social media, many health social media sites are now available for health consumers to discuss any healthrelated issues, including adverse drug reactions they encounter. There is a large volume of health-consumercontributed content available, but little effort has been made to harness this information for postmarketing drug safety surveillance to supplement the traditional approach. In this work, we propose the association rule mining approach to identify the association between a drug and an adverse drug reaction. We use the alerts posted by http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png ACM Transactions on Management Information Systems (TMIS) Association for Computing Machinery

Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media

Loading next page...
 
/lp/association-for-computing-machinery/postmarketing-drug-safety-surveillance-using-publicly-available-health-ZL9t6yDQSh
Publisher
Association for Computing Machinery
Copyright
Copyright © 2014 by ACM Inc.
ISSN
2158-656X
DOI
10.1145/2576233
Publisher site
See Article on Publisher Site

Abstract

Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media CHRISTOPHER C. YANG, HAODONG YANG, and LING JIANG, Drexel University Postmarketing drug safety surveillance is important because many potential adverse drug reactions cannot be identified in the premarketing review process. It is reported that about 5% of hospital admissions are attributed to adverse drug reactions and many deaths are eventually caused, which is a serious concern in public health. Currently, drug safety detection relies heavily on voluntarily reporting system, electronic health records, or relevant databases. There is often a time delay before the reports are filed and only a small portion of adverse drug reactions experienced by health consumers are reported. Given the popularity of social media, many health social media sites are now available for health consumers to discuss any healthrelated issues, including adverse drug reactions they encounter. There is a large volume of health-consumercontributed content available, but little effort has been made to harness this information for postmarketing drug safety surveillance to supplement the traditional approach. In this work, we propose the association rule mining approach to identify the association between a drug and an adverse drug reaction. We use the alerts posted by

Journal

ACM Transactions on Management Information Systems (TMIS)Association for Computing Machinery

Published: Apr 1, 2014

There are no references for this article.